SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Wockhardt planning to roll out two vaccines within year from UK-based facility

27 Feb 2023 Evaluate

Wockhardt is planning to roll out two vaccines within a year from its UK-based facility as part of a tie-up with Serum Institute of India. Last year, a Wockhardt unit tied up with a subsidiary of Serum Institute of India to set up a vaccine manufacturing facility in Wrexham, North Wales (UK).

Serum has identified two vaccines and the company plans to manufacture these products within the next 12 months after exhibit batches and regulatory approval is received.

Wockhardt is a research based global pharmaceutical and Biotech Company headquartered in Mumbai, India.

Wockhardt Share Price

1396.80 37.70 (2.77%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×